Heart Care Imaging (HCI) customers now have access to fluorodeoxyglucose. The PET radiotracer is being provided exclusively by Syncor International under a new two-year agreement. HCI clients include outpatient clinics, practice management groups, and
Heart Care Imaging (HCI) customers now have access to fluorodeoxyglucose. The PET radiotracer is being provided exclusively by Syncor International under a new two-year agreement. HCI clients include outpatient clinics, practice management groups, and hospitals in the mid-Atlantic and Southeastern U.S.
New CT Angiography Study Shows Impact of COVID-19 on Coronary Inflammation and Plaque
February 5th 2025Prior COVID-19 infection was associated with a 28 percent higher progression of total percent atheroma volume (PAV) annually and over a 5 percent higher incidence of high-risk plaque in patients with coronary artery lesions, according to CCTA findings from a new study.